Trading Update

RNS Number : 2774K

Advanced Medical Solutions Grp PLC

17 December 2008

 



For Immediate Release

17 December 2008

Advanced Medical Solutions Group plc 

('AMS' or 'the Company')

Trading Update

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces an update on current trading prior to its close period for the year to 31 December 2008. 

Dr. Geoffrey Vernon, Chairman of Advanced Medical Solutions Group plc, stated:

'The business has continued to make excellent progress during the second half of the year and I am pleased to report that the Group is trading at the top end of market expectations for the full year 2008.  During 2009, whilst a portion of the Company's dollar exposure is already locked in, the Company expects to obtain some benefit from a favourable dollar based exchange rate. 

'The outlook remains positive with the business continuing to make good progress with all of its key growth drivers.

'The silver alginate business continues to grow with two additional 510(k) approvals being received recently from the FDA - one for a non-adherent anti-microbial dressing and one for Silver Alginate IV. These approvals will allow us to further develop our product range and business in the US.

'Our ActivHeal^(R) woundcare range for the treatment of routine wounds continues to gain wider acceptance within NHS Hospital and Primary Care Trusts. 

'Kimberly-Clark Health Care recently extended the InteguSeal* microbial sealant range with the addition of IS-50. This smaller sized surgical skin sealant is ideally suited for orthopaedic procedures that involve small incision areas such as hands, feet and ankles.

'We continue to progress the US approval of our LiquiBand™ tissue adhesive. 510(k) applications have been submitted and are currently under review by the FDA, with entry into this key strategic market via marketing and distribution partners expected during 2009.

'Following the joint venture with Corpura BV announced earlier this year, we have initiated a number of development projects incorporating new technologies that can help improve wound healing using Corpura's polyurethane foam technology.'

The Company's preliminary results will be announced in March 2009.

-ENDS- 

For further information, please contact:

Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Mary Tavener, Finance Director www.admedsol.com	Tel: [phone]
Buchanan Communications	Tel: [phone]
Mark Court, Mary-Jane Johnson, Stasa Filiplic Teathers Shaun Dobson / Claes Spang	Tel: [phone]

Notes to Editors:

Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced woundcare products.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

The acquisition of 49.4% of Corpura BV in May 2008 strengthened AMS' position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

* Trademark of Kimberly-Clark Worldwide, Inc. © 2007 KCWW.

 

END

 

 

TSTIIFIEFELDLIT